31 results
8-K
BTAX
Biostax Corp.
14 Nov 23
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
4:22pm
of Each Exchange on Which Registered
Common
BSTAX
OTC PINK
SECTION 5 — CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02
Departure of Directors or Certain
8-K
BTAX
Biostax Corp.
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
of Each Exchange on Which Registered
Common
BTAX
OTC Pink
SECTION 5 — CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02
Departure of Directors or Certain
8-K
EX-99.1
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
management, and corporate governance. He is a trained immunologist. In addition, he is, among other things, an Associate Clinical Professor
8-K
EX-10.1
bomi7r7f1f dnbsw
11 Jun 18
Entry into a Material Definitive Agreement
12:00am
DRS/A
f1oh4ky34mm9vs7b3k7i
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
wyjnf
14 Oct 16
IPO registration
12:00am
8-K
EX-1.1
ta2t3iz7cz9
25 Jun 14
Entry into a Material Definitive Agreement
12:00am